Arcus biosciences to host conference call to discuss first-quarter 2024 financial results and pipeline update

Hayward, calif.--(business wire)--arcus biosciences (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will host a conference call and webcast on wednesday, may 8th, 2024 at 1:30 pm pt / 4:30 pm et to discuss details of the company's financial results and pipeline update for the quarter ended march 31st, 2024. investors interested in listening to the c.
RCUS Ratings Summary
RCUS Quant Ranking